[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343591-105":59,"doc-detail-343591-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","flavonoids-as-modulators-of-metabolic-reprogramming-in-renal-cell-carcinoma-review","Flavonoids as modulators of metabolic reprogramming in renal cell carcinoma - Review","","Renal cell carcinoma (RCC) exhibits diverse metabolic reprogramming driven by dysregulated tumor suppressors and activated oncogenes. Tumors adjust nutrient uptake and metabolic networks to satisfy biosynthetic, bioenergetic and redox requirements, while conventional chemotherapy and molecular inhibitors often focus on single pathways without covering this adaptability. Flavonoids, known for antioxidant and anti-inflammatory activity, may modulate multiple metabolic targets. This comprehensive review details RCC metabolic reprogramming processes including glycolysis, mitochondrial oxidative phosphorylation and fatty-acid biosynthesis, offering mechanistic insight into flavonoid-based anticancer strategies targeting RCC metabolism.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/flavonoids-as-modulators-of-metabolic-reprogramming-in-renal-cell-carcinoma-review/343591/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/flavonoids-as-modulators-of-metabolic-reprogramming-in-renal-cell-carcinoma-review/343591.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What metabolic reprogramming features characterize renal cell carcinoma (RCC)?","Question",{"text":112,"@type":113},"RCC displays altered metabolism that supports biosynthesis, energy production, and redox balance. Key processes discussed include glycolysis, mitochondrial oxidative phosphorylation, and fatty-acid biosynthesis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why are flavonoids considered promising for RCC treatment?",{"text":117,"@type":113},"Flavonoids can influence multiple metabolic targets and are associated with antioxidant and anti-inflammatory properties. The review links these effects to potential anticancer mechanisms centered on metabolic reprogramming.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the review say about limitations of conventional therapies for RCC metabolism?",{"text":121,"@type":113},"Conventional chemotherapeutics and molecular inhibitors mainly target individual metabolic pathways. This approach may not adequately address the tumor’s adaptability in nutrient utilization and metabolic network switching.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343591,1790698422,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","ONCOLOGY REPORTS 52: 167, 2024  \nFlavonoids as modulators of metabolic reprogramming in renal cell carcinoma (Review)  \nASIF SHAHZAD 1 , WENJING LIU 1 , YIJIAN SUN 1 , XIANGJIE LIU 1 , JIAOJIAO XIA 1 , KUN CUI 1 , BUQING SAI 1 , YUECHUN ZHU 1 , ZHE YANG2 and QIAO ZHANG 1  \n1  \nDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Kunming Medical University, Kunming, Yunnan 650500, P.R. China; 2Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China  \nReceived March 15, 2024; Accepted August 30, 2024  \nDOI: 10. 3892/or.2024.8826  \nAbstract. Renal cell carcinoma (RCC) is distinguished by its varied metabolic reprogramming driven by tumor suppressor gene dysregulation and oncogene activation. Tumors can adapt nutrient uptake and metabolism pathways to meet the altered biosynthetic, bioenergetic and redox demands of cancer cells, whereas conventional chemotherapeutics and molecular inhibitors predominantly target individual metabolic path‑ ways without addressing this adaptability. Flavonoids, which are well‑known for their antioxidant and anti‑inflammatory properties, offer a unique approach by influencing multiple metabolic targets. The present comprehensive review reveals the intricate processes of RCC metabolic reprogramming, encompassing glycolysis, mitochondrial oxidative phosphory‑ lation and fatty acid biosynthesis. The insights derived from the present review may contribute to the understanding of  \nCorrespondence to: Professor Qiao Zhang, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Kunming Medical University, 1168 Yuhua Road, Chenggong, Kunming, Yunnan 650500, P.R. China  \nE‑mail: [zhangqiao200824@126.com](zhangqiao200824@126.com)  \nProfessor Zhe Yang, Department of Pathology, The First Affiliated Hospital of Kunming Medical University, 295 Xichang Road, Wuhua, Kunming, Yunnan 650032, P.R. China  \nE‑mail: [zyangpku@163.com](zyangpku@163.com)  \nAbbreviations: RCC, renal cell carcinoma; ccRCC, clear cell renal cell carcinoma; GLUT, glucose transporter; ECG, epicatechingallate; EGCG, epigallocatechin‑3‑gallate; TCA, tricarboxylic acid; LDH, lactate dehydrogenase; LDHA, LDH A; PKM2, pyruvate kinase M2; HK, hexokinase; PDH, pyruvate dehydrogenase; ETC, electron transport chain; PPP, pentose phosphate pathway; 6PGD, 6‑phosphogluconate dehydrogenase; ACC, acetyl CoA carboxylase; FAS, fatty acid synthase; SCD, stearoyl CoA desaturase; LPA, lysophosphatidic acid; COX, cyclooxygenase; GLS, glutaminase; GPX1, glutathione peroxidase 1  \nKey words: flavonoids, metabolic reprogramming, Warburg effect, RCC, anticancer drug  \nthe specific anticancer mechanisms of flavonoids, potentially paving the way for the development of natural antitumor drugs focused on the metabolic reprogramming of RCC.  \nContents  \n1. Introduction  \n2. Anticancer drugs targeting metabolic reprogramming  \n3. Role of flavonoids in RCC metabolic reprogramming  \n4. Toxicity associated with flavonoids  \n5. Dietary bioactive compounds as chemopreventive agents  \n6. Combination therapy with bioactive compounds against cancer  \n7. Summary  \n8. Conclusion  \n1. Introduction  \nRenal cell carcinoma (RCC), also known as renal adeno‑ carcinoma, is a type of kidney cancer that arises from the renal tubule cells, representing 2‑3% of all adult cancers (1) . Each year, physicians identify an estimated 210,000 new instances of kidney cancer worldwide, making it the seventh most prevalent cancer in men and the ninth most common cancer in women (2) . The United States, northern Europe, Canada, Australia, and New Zealand have the highest rates of kidney cancer according to the National Cancer Institute. Thailand, the Philippines, and China have the lowest inci‑ dences (3) . Clear cell RCC (ccRCC) accounts for 70‑80% of RCC cases, while the other subtypes are primarily composed of chromophobe tumors (3‑5%) and papillary tumors (10‑15%) (4) . Furthermo","cbCaivsXEqqKxhNy","https://ap.wps.com/l/cbCaivsXEqqKxhNy","pdf",2212625,17,"English","# Contents\n## Introduction\n## Anticancer drugs targeting metabolic reprogramming\n## Role of flavonoids in RCC metabolic reprogramming\n## Toxicity associated with flavonoids\n## Dietary bioactive compounds as chemopreventive agents\n## Combination therapy with bioactive compounds against cancer\n## Summary\n## Conclusion","[{\"question\":\"What metabolic reprogramming features characterize renal cell carcinoma (RCC)?\",\"answer\":\"RCC displays altered metabolism that supports biosynthesis, energy production, and redox balance. Key processes discussed include glycolysis, mitochondrial oxidative phosphorylation, and fatty-acid biosynthesis.\"},{\"question\":\"Why are flavonoids considered promising for RCC treatment?\",\"answer\":\"Flavonoids can influence multiple metabolic targets and are associated with antioxidant and anti-inflammatory properties. The review links these effects to potential anticancer mechanisms centered on metabolic reprogramming.\"},{\"question\":\"What does the review say about limitations of conventional therapies for RCC metabolism?\",\"answer\":\"Conventional chemotherapeutics and molecular inhibitors mainly target individual metabolic pathways. This approach may not adequately address the tumor’s adaptability in nutrient utilization and metabolic network switching.\"}]","Flavonoids as modulators of metabolic reprogramming in renal cell carcinoma - Review | PDF",1790051512,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78b9fe758754563f0896b38717a60bfa.webp",983,1357,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3376fa6b9d64a965e0daa373d79d2965.webp",982,1356,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f82bbbbc780307c44d6c794c09ac6d9c.webp",981,1354,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e083a76f9b6d8314fc445c0c0c6affb3.webp",980,1353]